Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The P2X7 Receptor-Interleukin-1 Liaison.

Anna Lisa Giuliani1, Alba C Sarti1, Simonetta Falzoni1

  • 1Department of Morphology, Surgery and Experimental Medicine, University of Ferrara Ferrara, Italy.

Frontiers in Pharmacology
|April 1, 2017
PubMed
Summary

The P2X7 receptor (P2X7R) is crucial for Interleukin-1β (IL-1β) release, a key driver of inflammation. This review explores P2X7R

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of P2RX7 functional SNPs on osteoblast cell phenotype, function and signalling- roles in bone homeostasis and osteogenesis.

Purinergic signalling·2026
Same author

Participation of the purinergic P2X7 receptor in molecular complexes in the nucleus of human chondrocytes.

Cellular and molecular life sciences : CMLS·2026
Same author

P2X receptors in immune cells: key regulators of inflammation and immune function.

Neuropharmacology·2026
Same author

A bioluminescent ratiometric sensor for the measurement of extracellular ATP concentration in inflammation and cancer.

Neuropharmacology·2026
Same author

In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend.

Purinergic signalling·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

British journal of pharmacology·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Interleukin-1β (IL-1β) is central to innate immunity and inflammation, implicated in diseases like type II diabetes and atherosclerosis.
  • Understanding IL-1β synthesis and release is vital for developing new anti-inflammatory drugs.
  • The P2X7 receptor (P2X7R), an ATP-gated ion channel, is a key regulator of IL-1β maturation via the NLRP3 inflammasome-caspase-1 pathway.

Purpose of the Study:

  • To review the evidence highlighting the critical role of P2X7R in IL-1β production.
  • To focus on the controversial mechanisms of IL-1β release.
  • To discuss the implications for anti-inflammatory drug design.

Main Methods:

  • Literature review of studies investigating P2X7R and IL-1β.
Keywords:
NLRP3 inflammasomeP2X7 receptorcaspase-1inflammationinterleukin-1β

Related Experiment Videos

  • Analysis of proposed models for IL-1β release.
  • Examination of the P2X7R's involvement in these release pathways.

    • Main Results:

    • The P2X7 receptor (P2X7R) is consistently implicated in Interleukin-1β (IL-1β) production.
    • Four distinct models of IL-1β release are proposed: exocytosis, microvesicles, exosomes, and passive efflux.
    • All discussed release mechanisms involve the P2X7R.

    Conclusions:

    • The P2X7 receptor (P2X7R) is a pivotal mediator in Interleukin-1β (IL-1β) release.
    • Clarifying the precise IL-1β release mechanism involving P2X7R is essential for targeted anti-inflammatory therapies.
    • Further research into P2X7R-mediated IL-1β release pathways could lead to novel therapeutic strategies for inflammatory diseases.